Biotechnology

Biotechnology aims to create valuable products by exploiting existing biological processes or by developing new ones. This definition in particular includes approaches to gene-editing / synthetic biology

new cancer treatment

New Immunotherapy Method Shows Promise For Blocking Breast Cancer Treatment

PRESS RELEASE — Researchers have discovered the mechanism by which specific immune cells can block breast cancer development and even suppress a developed tumor. In mice studies, the team observed that CD4+ T helper (Th) 2 cells reverted high-grade breast tumors to making cells similar to a non-cancerous breast gland. The research is published in a …

New Immunotherapy Method Shows Promise For Blocking Breast Cancer Treatment Read More »

blue and black abstract painting

Stem Cell Therapy for Parkinson’s Disease Heads to Clinical Trials

UNIVERSITY NEWS — Neurodegenerative diseases damage and destroy neurons, ravaging both mental and physical health. Parkinson’s disease, which affects over 10 million people worldwide, is no exception. The most obvious symptoms of Parkinson’s disease arise after the illness damages a specific class of neuron located in the midbrain. The effect is to rob the brain …

Stem Cell Therapy for Parkinson’s Disease Heads to Clinical Trials Read More »

YouthBio Therapeutics Exits Stealth Mode

The longevity company develops gene therapies aimed at rejuvenation via partial reprogramming by Yamanaka factors PRESS RELEASE — SEATTLE/PRNewswire/ — YouthBio Therapeutics, a longevity biotechnology company, has announced this week its emergence out of stealth mode. YouthBio focuses on developing gene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors. The company was …

YouthBio Therapeutics Exits Stealth Mode Read More »

Stämm Secures $17M Series A Round

PRESS RELEASE — SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Stämm, a biotechnology company developing an innovative biomanufacturing platform of continuous and autonomous production at an industrial scale, today announced closing a Series A, securing $17M. Stämm will use this funding to prepare for commercialization of its technology; to further develop biopharma partnerships into pilot-scale; to enhance its operational …

Stämm Secures $17M Series A Round Read More »

Salk anti-aging research

Cellular Rejuvenation Therapy Safely Reverses Signs of Aging in Mice

RESEARCH NEWS RELEASE — Age may be just a number, but it’s a number that often carries unwanted side effects, from brittle bones and weaker muscles to increased risks of cardiovascular disease and cancer. Now, scientists at the Salk Institute, in collaboration with Genentech, a member of the Roche group, have shown that they can …

Cellular Rejuvenation Therapy Safely Reverses Signs of Aging in Mice Read More »

blue and black abstract painting

Actym Therapeutics and Wacker Biotech Sign Contract for Solid Tumor Treatment Candidate

PRESS RELEASE — Actym Therapeutics, a biotechnology company focused on the discovery and development of novel therapies intended to transform the treatment of cancer, and Wacker Biotech announced today that they have signed a contract for the manufacturing of Actym’s lead clinical candidate, ACTM-838, for the treatment of solid tumors. Under the terms of the …

Actym Therapeutics and Wacker Biotech Sign Contract for Solid Tumor Treatment Candidate Read More »

Israeli Startup CVAid Raises $4M, Including Investment by Philips For its AI-based Platform For Diagnosis of Strokes

PRESS RELEASE — TEL AVIV, Israel, Feb. 28, 2022 /PRNewswire/ — The Israeli digital health company CVAid Medical, which has developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of the capital raising from Philips together with Sanara Capital. The Israeli Rad Biomed investment fund led the capital …

Israeli Startup CVAid Raises $4M, Including Investment by Philips For its AI-based Platform For Diagnosis of Strokes Read More »

Automata Raises $50M in Series B Financing to Accelerate Automation in Life Sciences

LONDON/PRNewswire/ — Automata — the automation company helping life sciences rapidly innovate, diagnose and discover at scale — has announced it has raised $50 million in Series B funding. The investment round was led by Octopus Ventures with participation from returning investors Hummingbird, Latitude Ventures, ABB Technology Ventures, Isomer Capital as well as strategic investors such as In-Q-Tel, amongst others. This …

Automata Raises $50M in Series B Financing to Accelerate Automation in Life Sciences Read More »

Cambrian Biopharma Licenses mTOR Analogs to Novartis

PRESS RELEASE — Cambrian Biopharma, a multi-asset longevity biotech, announced a licensing agreement with Novartis to advance novel, selective compounds designed and characterized by Novartis to target the mechanistic target of rapamycin (mTOR) pathway. The licensed assets are structural analogs of the FDA-approved drug rapamycin, which has been shown to prevent or reverse multiple age-related health …

Cambrian Biopharma Licenses mTOR Analogs to Novartis Read More »